Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Locoregional Analgesia for Persistent Postoperative Pain in Children
NCT06271174Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mepivacaine in chronic post-surgical pain (CPSP), sponsored by CHU de Nantes. Started Jun 2024; status: recruiting.
02
Drugs
mepivacaine
03
Conditions
chronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT06271174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271174.